Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 21, 2019 - Ocular Therapeutix announced the FDA approval of Dextenza (dexamethasone), for the treatment of ocular inflammation and pain following ophthalmic surgery.
Return to publications